Skip to content
healthcare.dev

TELMISARTAN

NDC 62135-537, TELMISARTAN, tablet, from Chartwell RX, LLC..

Product NDC
62135-537
Status
Listed
Labeler
Chartwell RX, LLC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078710
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-537 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TELMISARTAN80 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]

Package NDCNDC-11Package
62135-537-306213505373030 TABLET in 1 BOTTLE (62135-537-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/beaaf383-730f-4411-b5e7-15c32b53a338
  • NADAC price for package 62135053730

    GET /v1/drugs/nadac/62135053730

Use it

Look up 62135-537 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-537 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-537. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.